Evaluation of real-world use of pulmonary embolism thrombolysis: ERUPT
PE thrombolysis in the UK deviates from international guidelines in a significant minority of cases; comprising the use of reduced-dose regimens and thrombolysis in non-high-risk cases without haemodynamic deterioration. Prospective real-world studies, assessing clinical practice and outcomes following thrombolysis, should be conducted to understand the pragmatic application of evidence and inform future guidelines.
Authors
- Ross Thompson
- Kay‐Pong Yip (ORCID: https://orcid.org/0000-0003-4364-6701)
- Cecillia Rafique
- Ruth Sobala (ORCID: https://orcid.org/0000-0002-6185-9244)
- Romit Samanta (ORCID: https://orcid.org/0000-0003-0828-3183)
- Najib Mahboob Rahman (ORCID: https://orcid.org/0000-0003-1195-1680)
- Joseph Kibbler (ORCID: https://orcid.org/0000-0002-4504-5099)
- Anthony De Soyza (ORCID: https://orcid.org/0000-0002-8566-0344)
- Akhilesh Jha (ORCID: https://orcid.org/0000-0002-8413-7738)
- Matthew Steward (ORCID: https://orcid.org/0000-0002-1873-4665)
Institutions
- University of Cambridge (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Northumbria Healthcare NHS Foundation Trust (GB)
- Churchill Hospital (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Freeman Hospital (GB)
- Northern Devon Healthcare NHS Trust (GB)
- South Tyneside and Sunderland NHS Foundation Trust (GB)
- University of Birmingham (GB)
- Newcastle University (GB)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1183/23120541.00935-2024
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Asthma and Lung UK